AAAAAA

   
Results: 1-12 |
Results: 12
CONSTRUCTION OF INFECTIOUS CDNA CLONES FOR DENGUE-2 VIRUS - STRAIN-16681 AND ITS ATTENUATED VACCINE DERIVATIVE, STRAIN PDK-53
Authors: KINNEY RM BUTRAPET S CHANG GJJ TSUCHIYA KR ROEHRIG JT BHAMARAPRAVATI N GUBLER DJ
Citation: Rm. Kinney et al., CONSTRUCTION OF INFECTIOUS CDNA CLONES FOR DENGUE-2 VIRUS - STRAIN-16681 AND ITS ATTENUATED VACCINE DERIVATIVE, STRAIN PDK-53, Virology, 230(2), 1997, pp. 300-308
THE MICRO-FOCUS REDUCTION NEUTRALIZATION TEST FOR DETERMINING DENGUE AND JAPANESE ENCEPHALITIS NEUTRALIZING ANTIBODIES IN VOLUNTEERS VACCINATED AGAINST DENGUE
Authors: JIRAKANJANAKIT N SANOHSOMNEING T YOKSAN S BHAMARAPRAVATI N
Citation: N. Jirakanjanakit et al., THE MICRO-FOCUS REDUCTION NEUTRALIZATION TEST FOR DETERMINING DENGUE AND JAPANESE ENCEPHALITIS NEUTRALIZING ANTIBODIES IN VOLUNTEERS VACCINATED AGAINST DENGUE, Transactions of the Royal Society of Tropical Medicine and Hygiene, 91(5), 1997, pp. 614-617
TESTING OF A DENGUE 2 LIVE-ATTENUATED VACCINE (STRAIN 16681 PDK 53) IN 10 AMERICAN VOLUNTEERS
Authors: VAUGHN DW HOKE CH YOKSAN S LACHANCE R INNIS BL RICE RM BHAMARAPRAVATI N
Citation: Dw. Vaughn et al., TESTING OF A DENGUE 2 LIVE-ATTENUATED VACCINE (STRAIN 16681 PDK 53) IN 10 AMERICAN VOLUNTEERS, Vaccine, 14(4), 1996, pp. 329-336
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF A NEW MONOCLONAL-ANTIBODY REACTIVE WITH DENGUE VIRUS-INFECTED CELLS IN FROZEN TISSUE USING IMMUNOPEROXIDASE TECHNIQUE
Authors: BHOOPAT L BHAMARAPRAVATI N ATTASIRI C YOKSARN S CHAIWUN B KHUNAMOMPONG S SIRISANTHANA V
Citation: L. Bhoopat et al., IMMUNOHISTOCHEMICAL CHARACTERIZATION OF A NEW MONOCLONAL-ANTIBODY REACTIVE WITH DENGUE VIRUS-INFECTED CELLS IN FROZEN TISSUE USING IMMUNOPEROXIDASE TECHNIQUE, Asian Pacific Journal of Allergy and Immunology, 14(2), 1996, pp. 107-113
LANGERHANS CELL-DENSITY AND SEROLOGICAL CHANGES FOLLOWING INTRADERMALIMMUNIZATION OF MICE WITH DENGUE-2 VIRUS
Authors: TAWEECHAISUPAPONG S SRIURAIRATANA S ANGSUBHAKORN S YOKSAN S KHIN MM SAHAPHONG S BHAMARAPRAVATI N
Citation: S. Taweechaisupapong et al., LANGERHANS CELL-DENSITY AND SEROLOGICAL CHANGES FOLLOWING INTRADERMALIMMUNIZATION OF MICE WITH DENGUE-2 VIRUS, Journal of Medical Microbiology, 45(2), 1996, pp. 138-145
A COMPARATIVE-STUDY OF HUMAN EPIDERMAL LANGERHANS CELL DENSITIES IN 10 ANATOMICAL SITES IN HEALTHY AND DISEASED SKIN
Authors: TAWEECHAISUPAPONG S ANGSUBHAKORN S SRIURAIRATANA S BHAMARAPRAVATI N
Citation: S. Taweechaisupapong et al., A COMPARATIVE-STUDY OF HUMAN EPIDERMAL LANGERHANS CELL DENSITIES IN 10 ANATOMICAL SITES IN HEALTHY AND DISEASED SKIN, British journal of dermatology, 134(1), 1996, pp. 187-188
DIAGNOSING DENGUE VIRUS-INFECTION IN ARCHIVED AUTOPSY TISSUES BY MEANS OF THE IN-SITU PCR METHOD - A CASE-REPORT
Authors: KANGWANPONG D BHAMARAPRAVATI N LUCIA HL
Citation: D. Kangwanpong et al., DIAGNOSING DENGUE VIRUS-INFECTION IN ARCHIVED AUTOPSY TISSUES BY MEANS OF THE IN-SITU PCR METHOD - A CASE-REPORT, Clinical and diagnostic virology, 3(2), 1995, pp. 165-172
ALTERATIONS IN VASCULAR ENDOTHELIAL CELL-RELATED PLASMA-PROTEINS IN THALASSEMIC PATIENTS AND THEIR CORRELATION WITH CLINICAL SYMPTOMS
Authors: BUTTHEP P BUNYARATVEJ A FUNAHARA Y KITAGUCHI H FUCHAROEN S SATO S BHAMARAPRAVATI N
Citation: P. Butthep et al., ALTERATIONS IN VASCULAR ENDOTHELIAL CELL-RELATED PLASMA-PROTEINS IN THALASSEMIC PATIENTS AND THEIR CORRELATION WITH CLINICAL SYMPTOMS, Thrombosis and haemostasis, 74(4), 1995, pp. 1045-1049
SCIENTIFIC AND PUBLIC-HEALTH RATIONALE FOR HIV VACCINE EFFICACY TRIALS
Authors: AHOUANTO M ANDERSON R BARBOSA J BELOQUI J BHAMARAPRAVATI N BURKE D DECASTILHO EA CLEMENTS ML COUTINHO R FAST P GIRARD M GNAORE E HAASE A JAFFE H JOHNSTON M KALEEBA N KALLINGS L LEVY JP MBIDDE M MOORE J ABBING ER SCHULTZ A THONGCHAROEN P TRIPATHY S WIGZELL H DULIEGE AM WALKER C OBIJESKI J FRANCIS D BERMAN P MANNHALTER J EXCLER JL DEWILDE M PANICALI D MERSON MH PIOT P ESPARZA J OSMANOV S HEYWARD W MANE P FERRY B SCHOPPER D
Citation: M. Ahouanto et al., SCIENTIFIC AND PUBLIC-HEALTH RATIONALE FOR HIV VACCINE EFFICACY TRIALS, AIDS, 9(3), 1995, pp. 1-4
FEASIBILITY OF DEVELOPING LIVE ATTENUATED HIV VACCINES - CONCLUSIONS AND RECOMMENDATIONS
Authors: BALAYAN M BHAMARAPRAVATI N BURKE D CHANDLER DK DESROSIERS R SCHILD G SCHULTZ A SHAW GM STOTT J WEISS R WIGZELL H DOWDLE WR GIRARD M GOUDSMIT J GUIMARAES CS KIENY MP MBIDDE EK ROSCAMABBING EW ESPARZA J HEYMANN DL HEYWARD WL KALLINGS LO MERSON MH OSMANOV S SABA J
Citation: M. Balayan et al., FEASIBILITY OF DEVELOPING LIVE ATTENUATED HIV VACCINES - CONCLUSIONS AND RECOMMENDATIONS, AIDS research and human retroviruses, 10(2), 1994, pp. 221-222
DENGUE VIRUS-SPECIFIC MEMORY T-CELL RESPONSES IN HUMAN VOLUNTEERS RECEIVING A LIVE ATTENUATED DENGUE VIRUS TYPE-2 CANDIDATE VACCINE
Authors: DHARAKUL T KURANE I BHAMARAPRAVATI N YOKSAN S VAUGHN DW HOKE CH ENNIS FA
Citation: T. Dharakul et al., DENGUE VIRUS-SPECIFIC MEMORY T-CELL RESPONSES IN HUMAN VOLUNTEERS RECEIVING A LIVE ATTENUATED DENGUE VIRUS TYPE-2 CANDIDATE VACCINE, The Journal of infectious diseases, 170(1), 1994, pp. 27-33
INFECTION, DISSEMINATION, TRANSMISSION, AND BIOLOGICAL ATTRIBUTES OF DENGUE-2 PDK53 CANDIDATE VACCINE VIRUS AFTER ORAL INFECTION IN AEDES-AEGYPTI
Authors: KHIN MM JIRAKANJANAKIT N YOKSAN S BHAMARAPRAVATI N
Citation: Mm. Khin et al., INFECTION, DISSEMINATION, TRANSMISSION, AND BIOLOGICAL ATTRIBUTES OF DENGUE-2 PDK53 CANDIDATE VACCINE VIRUS AFTER ORAL INFECTION IN AEDES-AEGYPTI, The American journal of tropical medicine and hygiene, 51(6), 1994, pp. 864-869
Risultati: 1-12 |